Results 271 to 280 of about 3,152,690 (357)

Risk of Dementia After Electroconvulsive Therapy: A Cohort Study on the Population of Wales

open access: yesActa Psychiatrica Scandinavica, EarlyView.
ABSTRACT Background Electroconvulsive therapy (ECT) is the most effective therapy for severe or treatment‐resistant depression. A common short‐term side effect is memory problems, and it is important to know whether ECT increases the risk for dementia later in life.
George Kirov   +3 more
wiley   +1 more source

Opportunities and Challenges of Population Pharmacogenomics

open access: yesAnnals of Human Genetics, EarlyView.
ABSTRACT Pharmacological responses can vary significantly among patients from different ethnogeographic backgrounds. This variability can, at least in part, be attributed to population‐specific genetic patterns in genes involved in drug absorption, distribution, metabolism, and excretion, as well as in genes associated with drug‐induced toxicity ...
Yitian Zhou   +3 more
wiley   +1 more source

Aspirin for stroke prevention taken in the evening? [PDF]

open access: yes, 2004
Bódis, József   +2 more
core  

An exploratory analysis of 5‐alpha reductase inhibitors and risk of opioid use disorder among male Medicare beneficiaries receiving prescription opioid medications

open access: yesThe American Journal on Addictions, EarlyView.
Abstract Background Opioid use disorder (OUD) imposes a significant socioeconomic burden, highlighting the need for new interventions. Objective This study investigated whether exposure to 5‐alpha reductase inhibitors (5αRIs) is associated with a lower risk of developing OUD.
Abdelrahman G. Tawfik   +5 more
wiley   +1 more source

Sex and gender [PDF]

open access: yes, 2010
Hyde, Martin   +2 more
core  

Integrated Efficacy and Safety Analysis of Abrocitinib in Adolescents With Moderate‐to‐Severe Atopic Dermatitis

open access: yesAllergy, EarlyView.
Data were included from adolescents with moderate‐to‐severe AD treated with the JAK1 inhibitor abrocitinib (200 mg/100 mg) across JADE clinical trials. Improvements in skin clearance (per EASI‐75) and itch (per PP‐NRS4) were maintained for up to 112 weeks with both abrocitinib doses.
Amy S. Paller   +13 more
wiley   +1 more source

Anxiety and depressive disorders in patients with diabetes mellitus type 2 and cerebrovascular disease

open access: diamond, 2012
И И Дубинина   +3 more
openalex   +2 more sources

Reproductive functions and fertility preservation in men with sickle cell disease

open access: yesAndrology, EarlyView.
Abstract Background Sickle cell disease (SCD) is a prevalent hereditary disorder with significant morbidity, including potential impacts on male fertility. This study aims to evaluate the semen parameters in men with SCD and assess the outcomes of fertility preservation strategies.
Clarisse Leblanc   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy